Some good news
The first major study of an experimental vaccine to prevent cervical cancer found it was 100 percent effective, in the short term, at blocking the disease and lesions likely to turn cancerous, the drugmaker Merck & Co. said Thursday. Its shares rose nearly 6 percent.Expect the Usual Suspects to try to block the vaccine as 'encouraging sexual activity' or some such crap... Seriously. Wait for it.
"You have to get students in grammar school, middle school, high school (vaccinated) before they become sexually active," she said.